BRPI0820877A2 - remédios para pênfigo contendo anticorpos ligantes anti faz - Google Patents

remédios para pênfigo contendo anticorpos ligantes anti faz

Info

Publication number
BRPI0820877A2
BRPI0820877A2 BRPI0820877A BRPI0820877A BRPI0820877A2 BR PI0820877 A2 BRPI0820877 A2 BR PI0820877A2 BR PI0820877 A BRPI0820877 A BR PI0820877A BR PI0820877 A BRPI0820877 A BR PI0820877A BR PI0820877 A2 BRPI0820877 A2 BR PI0820877A2
Authority
BR
Brazil
Prior art keywords
pemphigus
binding antibodies
containing anti
remedies containing
anti binding
Prior art date
Application number
BRPI0820877A
Other languages
English (en)
Inventor
Marconi Alessandra
Pincelli Carlo
Original Assignee
Pincell Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pincell Srl filed Critical Pincell Srl
Publication of BRPI0820877A2 publication Critical patent/BRPI0820877A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2875—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF/TNF superfamily, e.g. CD70, CD95L, CD153, CD154
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Luminescent Compositions (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BRPI0820877A 2007-12-12 2008-12-12 remédios para pênfigo contendo anticorpos ligantes anti faz BRPI0820877A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1314707P 2007-12-12 2007-12-12
US5180108P 2008-05-09 2008-05-09
PCT/EP2008/010597 WO2009074339A1 (en) 2007-12-12 2008-12-12 Remedies for pemphigus containing anti fas ligand antobodies

Publications (1)

Publication Number Publication Date
BRPI0820877A2 true BRPI0820877A2 (pt) 2017-06-06

Family

ID=40565064

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0820877A BRPI0820877A2 (pt) 2007-12-12 2008-12-12 remédios para pênfigo contendo anticorpos ligantes anti faz

Country Status (21)

Country Link
US (1) US20110038867A1 (pt)
EP (1) EP2231708B1 (pt)
JP (1) JP2011506371A (pt)
KR (1) KR20100130584A (pt)
CN (1) CN101918449A (pt)
AU (1) AU2008334912B8 (pt)
BR (1) BRPI0820877A2 (pt)
CA (1) CA2708790A1 (pt)
DK (1) DK2231708T3 (pt)
ES (1) ES2538489T3 (pt)
HR (2) HRP20150457T1 (pt)
HU (1) HUE025525T2 (pt)
IL (1) IL206280A0 (pt)
MX (1) MX2010006450A (pt)
NZ (2) NZ586148A (pt)
PL (1) PL2231708T3 (pt)
PT (1) PT2231708E (pt)
RU (1) RU2558260C2 (pt)
SI (1) SI2231708T1 (pt)
WO (1) WO2009074339A1 (pt)
ZA (1) ZA201004271B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2376536B1 (en) * 2008-12-12 2015-02-25 Pincell Srl Remedies for pemphigus containing anti fas ligand antibodies
JP2014504594A (ja) * 2011-01-10 2014-02-24 オプコ ファーマシューティカルズ、エルエルシー 自己免疫疾患における抗原代用物
CN105814079B (zh) 2013-08-30 2021-02-09 伊缪诺金公司 用于检测叶酸受体1的抗体和测定
CN104645303B (zh) * 2015-03-23 2017-12-08 重庆妙坤生物科技有限责任公司 一种治疗类天疱疮的中药组合物
KR102700777B1 (ko) 2015-09-17 2024-08-29 이뮤노젠 아이엔씨 항-folr1 면역접합체를 포함하는 치료제 조합
WO2017156058A1 (en) * 2016-03-08 2017-09-14 Janssen Biotech, Inc. Gitr antibodies, methods, and uses
EA037973B1 (ru) * 2016-10-12 2021-06-18 Янссен Байотек, Инк. Антитела к gitr, способы и применение
KR20240112934A (ko) * 2021-12-01 2024-07-19 인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) 중화 항-cd95l 모노클론 항체

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU716731B2 (en) * 1995-03-20 2000-03-02 Ko Okumura Monoclonal antibody reacting specifically with Fas ligand and process for producing the same
JP3925663B2 (ja) * 1995-06-30 2007-06-06 持田製薬株式会社 抗Ｆａｓリガンド抗体および該抗体を用いた測定法
US6114507A (en) * 1995-06-30 2000-09-05 Mochida Pharmaceutical Co., Ltd. Anti-Fas ligand antibody and assay method using the anti-Fas ligand antibody
CA2264968A1 (en) * 1996-09-02 1998-03-12 Ko Okumura Humanized immunoglobulin reacting specifically with fas ligand or active fragments thereof and region inducing apoptosis originating in fas ligand
US7262277B2 (en) * 2002-03-21 2007-08-28 Eli Lilly And Company Antagonistic anti-hFAS ligand human antibodies and fragments thereof
FR2933264B1 (fr) * 2008-06-25 2012-10-26 Actimagine Procede d'authentification d'un utilisateur d'un service sur terminal mobile.

Also Published As

Publication number Publication date
AU2008334912B2 (en) 2013-09-26
HRP20150409T1 (hr) 2015-05-22
HUE025525T2 (en) 2016-05-30
KR20100130584A (ko) 2010-12-13
RU2558260C2 (ru) 2015-07-27
NZ586148A (en) 2012-11-30
ZA201004271B (en) 2011-03-30
IL206280A0 (en) 2010-12-30
EP2231708B1 (en) 2015-04-08
AU2008334912A1 (en) 2009-06-18
HRP20150457T1 (hr) 2015-06-05
PT2231708E (pt) 2015-07-30
WO2009074339A1 (en) 2009-06-18
EP2231708A1 (en) 2010-09-29
CN101918449A (zh) 2010-12-15
ES2538489T3 (es) 2015-06-22
NZ602964A (en) 2013-06-28
AU2008334912B8 (en) 2013-10-24
US20110038867A1 (en) 2011-02-17
JP2011506371A (ja) 2011-03-03
RU2010128556A (ru) 2012-01-20
CA2708790A1 (en) 2009-06-18
DK2231708T3 (en) 2015-07-13
PL2231708T3 (pl) 2015-09-30
SI2231708T1 (sl) 2015-06-30
MX2010006450A (es) 2010-12-15

Similar Documents

Publication Publication Date Title
CY2019004I2 (el) Τροποποιημενα αντισωματα αντι-ιl-23ρ19
BRPI0820877A2 (pt) remédios para pênfigo contendo anticorpos ligantes anti faz
FI20070853A0 (fi) Glykaania sitovat monoklonaaliset vasta-aineet
CR10705A (es) Anticuerpos para linfotoxina-alfa
BRPI0919879A2 (pt) métodos para purificação de moléculas de ligação a antígeno de domínio único
BRPI0815075A2 (pt) Aglutinantes
PT2656823E (pt) Dispositivo cirúrgico oftálmico para capsulotomia
BRPI0916791A2 (pt) dispositivo para isntalação de fecho com cartucho descartável para redução de volume gástrico
BRPI0812744A2 (pt) Métodos para melhoramento molecular direcionado por sequência
BRPI0808814A2 (pt) Anticorpos monoclonais para o tratamento do câncer
BRPI0909016A2 (pt) anticorpos úteis para o tratamento do câncer
ZA201104130B (en) Remedies for pemphigus containing anti fas ligand antibodies
BRPI0812144A2 (pt) Recipiente para substâncias voláteis
BRPI0819448A2 (pt) Método para transações seguras
EP2108522A4 (en) Binder
BRPI0807084A2 (pt) Anticorpos específicos para o virus varicela zoster
BRPI0807650A2 (pt) Fecho rosqueado para conexão rosqueada
ES1065948Y (es) Dispositivo acustico para vehiculos
ES1066798Y (es) Bancada para vehiculos slot
ES1065801Y (es) Cierre para bolsas
ES1066304Y (es) Bisagra para canapes
ES1065439Y (es) Emisor para riego por goteo
ES1061806Y (es) Cercado perfeccionado para cerramiento
ES1065374Y (es) Cierre para bovedillas
ES1062419Y (es) Cierre para bolsos

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]